Titre : Mécanismes moléculaires de l'action pharmacologique

Mécanismes moléculaires de l'action pharmacologique : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment identifier un mécanisme d'action d'un médicament ?

L'analyse des interactions moléculaires et des voies de signalisation aide à identifier les mécanismes.
Mécanismes d'action Pharmacologie
#2

Quels tests sont utilisés pour étudier les mécanismes moléculaires ?

Des tests in vitro, des études de liaison et des analyses génétiques sont couramment utilisés.
Tests in vitro Analyse génétique
#3

Quelles techniques d'imagerie aident au diagnostic ?

L'imagerie par résonance magnétique et la tomographie permettent d'observer les effets des médicaments.
Imagerie médicale Tomographie
#4

Comment les biomarqueurs sont-ils utilisés dans le diagnostic ?

Les biomarqueurs aident à évaluer l'efficacité et la sécurité des médicaments en fonction de leur mécanisme.
Biomarqueurs Pharmacogénomique
#5

Quel rôle joue la pharmacogénomique dans le diagnostic ?

Elle permet d'adapter les traitements en fonction des variations génétiques influençant les mécanismes d'action.
Pharmacogénomique Génétique

Symptômes 5

#1

Quels symptômes indiquent un effet pharmacologique ?

Les symptômes peuvent inclure des changements physiologiques, des effets secondaires ou des améliorations cliniques.
Effets secondaires Symptômes
#2

Comment les effets indésirables sont-ils liés aux mécanismes d'action ?

Les effets indésirables résultent souvent d'interactions non spécifiques avec des cibles moléculaires.
Effets indésirables Interactions médicamenteuses
#3

Quels symptômes sont associés aux médicaments ciblant les récepteurs ?

Les symptômes peuvent inclure des modifications de la perception, de l'humeur ou de la douleur.
Récepteurs Symptômes
#4

Comment les symptômes varient-ils selon les mécanismes d'action ?

Les symptômes varient en fonction des cibles moléculaires et des voies de signalisation affectées.
Voies de signalisation Pharmacologie
#5

Quels symptômes peuvent indiquer une surdose ?

Des symptômes tels que des nausées, des vertiges ou des troubles de la conscience peuvent indiquer une surdose.
Surdose Symptômes

Prévention 5

#1

Comment prévenir les effets indésirables des médicaments ?

Une évaluation des mécanismes d'action et des interactions médicamenteuses peut aider à prévenir les effets indésirables.
Prévention Effets indésirables
#2

Quel rôle joue l'éducation des patients dans la prévention ?

L'éducation des patients sur les mécanismes d'action des médicaments peut améliorer l'adhésion et réduire les risques.
Éducation des patients Adhésion au traitement
#3

Comment les études cliniques aident-elles à prévenir les complications ?

Les études cliniques identifient les mécanismes d'action et les effets indésirables potentiels, permettant une meilleure prévention.
Études cliniques Complications
#4

Quels facteurs influencent la prévention des effets indésirables ?

Les facteurs incluent la génétique, l'âge, les comorbidités et les interactions médicamenteuses.
Facteurs de risque Interactions médicamenteuses
#5

Comment les recommandations de traitement aident-elles à prévenir les risques ?

Les recommandations basées sur les mécanismes d'action aident à choisir des traitements plus sûrs et efficaces.
Recommandations de traitement Sécurité des médicaments

Traitements 5

#1

Comment les médicaments ciblent-ils des mécanismes spécifiques ?

Les médicaments sont conçus pour interagir avec des cibles moléculaires spécifiques, comme des enzymes ou des récepteurs.
Cibles moléculaires Médicaments
#2

Quels traitements utilisent des mécanismes d'action innovants ?

Les thérapies géniques et les médicaments biologiques exploitent des mécanismes d'action novateurs.
Thérapie génique Médicaments biologiques
#3

Comment les traitements sont-ils personnalisés ?

Les traitements sont adaptés en fonction des caractéristiques moléculaires des patients et des médicaments.
Médecine personnalisée Pharmacogénomique
#4

Quel est l'impact des mécanismes d'action sur l'efficacité des traitements ?

Une compréhension approfondie des mécanismes d'action permet d'optimiser l'efficacité et de réduire les effets secondaires.
Efficacité Mécanismes d'action
#5

Comment les combinaisons de médicaments exploitent les mécanismes d'action ?

Les combinaisons de médicaments peuvent cibler plusieurs mécanismes pour améliorer l'efficacité thérapeutique.
Thérapies combinées Mécanismes d'action

Complications 5

#1

Quelles complications peuvent survenir avec des médicaments ?

Les complications peuvent inclure des réactions allergiques, des effets toxiques ou des interactions médicamenteuses.
Complications Réactions allergiques
#2

Comment les mécanismes d'action influencent-ils les complications ?

Les mécanismes d'action peuvent déterminer la sévérité et la nature des complications observées.
Mécanismes d'action Sévérité des complications
#3

Quels sont les signes de complications graves ?

Des signes tels que des difficultés respiratoires, des éruptions cutanées ou des douleurs thoraciques peuvent indiquer des complications graves.
Signes cliniques Complications graves
#4

Comment gérer les complications liées aux médicaments ?

La gestion des complications implique l'arrêt du médicament, le traitement des symptômes et la surveillance étroite.
Gestion des complications Surveillance médicale
#5

Quel rôle joue la pharmacovigilance dans la détection des complications ?

La pharmacovigilance surveille les effets indésirables et les complications pour améliorer la sécurité des médicaments.
Pharmacovigilance Sécurité des médicaments

Facteurs de risque 5

#1

Quels facteurs de risque influencent l'efficacité des médicaments ?

Les facteurs incluent l'âge, le sexe, la génétique et les comorbidités qui peuvent affecter l'efficacité.
Facteurs de risque Efficacité des médicaments
#2

Comment les interactions médicamenteuses sont-elles un facteur de risque ?

Les interactions médicamenteuses peuvent altérer les mécanismes d'action et augmenter le risque d'effets indésirables.
Interactions médicamenteuses Effets indésirables
#3

Quel impact a l'alimentation sur les mécanismes d'action ?

L'alimentation peut influencer l'absorption et le métabolisme des médicaments, affectant leur efficacité.
Alimentation Métabolisme des médicaments
#4

Comment le mode de vie affecte-t-il les traitements ?

Le mode de vie, y compris l'exercice et le tabagisme, peut modifier la réponse aux médicaments et leurs mécanismes d'action.
Mode de vie Réponse au traitement
#5

Quels facteurs environnementaux influencent les effets des médicaments ?

Les facteurs environnementaux, comme la pollution, peuvent interagir avec les mécanismes d'action des médicaments.
Facteurs environnementaux Pollution
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mécanismes moléculaires de l'action pharmacologique : Questions médicales les plus fréquentes", "headline": "Mécanismes moléculaires de l'action pharmacologique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mécanismes moléculaires de l'action pharmacologique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-16", "dateModified": "2025-02-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mécanismes moléculaires de l'action pharmacologique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Actions pharmacologiques", "url": "https://questionsmedicales.fr/mesh/D020228", "about": { "@type": "MedicalCondition", "name": "Actions pharmacologiques", "code": { "@type": "MedicalCode", "code": "D020228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs aux angiotensines", "alternateName": "Angiotensin Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D057911", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs aux angiotensines", "code": { "@type": "MedicalCode", "code": "D057911", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.162" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur de type 1 de l'angiotensine-II", "alternateName": "Angiotensin II Type 1 Receptor Blockers", "url": "https://questionsmedicales.fr/mesh/D047228", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur de type 1 de l'angiotensine-II", "code": { "@type": "MedicalCode", "code": "D047228", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.162.500" } } }, { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur de type 2 de l'angiotensine-II", "alternateName": "Angiotensin II Type 2 Receptor Blockers", "url": "https://questionsmedicales.fr/mesh/D057912", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur de type 2 de l'angiotensine-II", "code": { "@type": "MedicalCode", "code": "D057912", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.162.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Agents antiglycation", "alternateName": "Antiglycation Agents", "url": "https://questionsmedicales.fr/mesh/D000093744", "about": { "@type": "MedicalCondition", "name": "Agents antiglycation", "code": { "@type": "MedicalCode", "code": "D000093744", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.182" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la synthèse d'acides gras", "alternateName": "Fatty Acid Synthesis Inhibitors", "url": "https://questionsmedicales.fr/mesh/D054872", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la synthèse d'acides gras", "code": { "@type": "MedicalCode", "code": "D054872", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.186.071.401" } } }, { "@type": "MedicalWebPage", "name": "Piégeurs de radicaux libres", "alternateName": "Free Radical Scavengers", "url": "https://questionsmedicales.fr/mesh/D016166", "about": { "@type": "MedicalCondition", "name": "Piégeurs de radicaux libres", "code": { "@type": "MedicalCode", "code": "D016166", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.217.500" } } }, { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs de la bradykinine", "alternateName": "Bradykinin Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065168", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs de la bradykinine", "code": { "@type": "MedicalCode", "code": "D065168", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.265" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur B1 de la bradykinine", "alternateName": "Bradykinin B1 Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065169", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur B1 de la bradykinine", "code": { "@type": "MedicalCode", "code": "D065169", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.265.249" } } } ] }, { "@type": "MedicalWebPage", "name": "Agents de déplétion en cystine", "alternateName": "Cystine Depleting Agents", "url": "https://questionsmedicales.fr/mesh/D065104", "about": { "@type": "MedicalCondition", "name": "Agents de déplétion en cystine", "code": { "@type": "MedicalCode", "code": "D065104", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.334" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs des enzymes du cytochrome P-450", "alternateName": "Cytochrome P-450 Enzyme Inducers", "url": "https://questionsmedicales.fr/mesh/D065693", "about": { "@type": "MedicalCondition", "name": "Inducteurs des enzymes du cytochrome P-450", "code": { "@type": "MedicalCode", "code": "D065693", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP1A2", "alternateName": "Cytochrome P-450 CYP1A2 Inducers", "url": "https://questionsmedicales.fr/mesh/D065694", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP1A2", "code": { "@type": "MedicalCode", "code": "D065694", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.120" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2B6", "alternateName": "Cytochrome P-450 CYP2B6 Inducers", "url": "https://questionsmedicales.fr/mesh/D065695", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2B6", "code": { "@type": "MedicalCode", "code": "D065695", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.260" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2C8", "alternateName": "Cytochrome P-450 CYP2C8 Inducers", "url": "https://questionsmedicales.fr/mesh/D065696", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2C8", "code": { "@type": "MedicalCode", "code": "D065696", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.308" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2C9", "alternateName": "Cytochrome P-450 CYP2C9 Inducers", "url": "https://questionsmedicales.fr/mesh/D065698", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2C9", "code": { "@type": "MedicalCode", "code": "D065698", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.320" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2C19", "alternateName": "Cytochrome P-450 CYP2C19 Inducers", "url": "https://questionsmedicales.fr/mesh/D065697", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2C19", "code": { "@type": "MedicalCode", "code": "D065697", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.350" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2D6", "alternateName": "Cytochrome P-450 CYP2D6 Inducers", "url": "https://questionsmedicales.fr/mesh/D065699", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2D6", "code": { "@type": "MedicalCode", "code": "D065699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.500" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP2E1", "alternateName": "Cytochrome P-450 CYP2E1 Inducers", "url": "https://questionsmedicales.fr/mesh/D065700", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP2E1", "code": { "@type": "MedicalCode", "code": "D065700", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.600" } } }, { "@type": "MedicalWebPage", "name": "Inducteurs du cytochrome P-450 CYP3A", "alternateName": "Cytochrome P-450 CYP3A Inducers", "url": "https://questionsmedicales.fr/mesh/D065701", "about": { "@type": "MedicalCondition", "name": "Inducteurs du cytochrome P-450 CYP3A", "code": { "@type": "MedicalCode", "code": "D065701", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.349.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Antagonistes des récepteurs de l'endothéline", "alternateName": "Endothelin Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065128", "about": { "@type": "MedicalCondition", "name": "Antagonistes des récepteurs de l'endothéline", "code": { "@type": "MedicalCode", "code": "D065128", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.364" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur de type A de l'endothéline", "alternateName": "Endothelin A Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065130", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur de type A de l'endothéline", "code": { "@type": "MedicalCode", "code": "D065130", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.364.500" } } }, { "@type": "MedicalWebPage", "name": "Antagonistes du récepteur de type B de l'endothéline", "alternateName": "Endothelin B Receptor Antagonists", "url": "https://questionsmedicales.fr/mesh/D065131", "about": { "@type": "MedicalCondition", "name": "Antagonistes du récepteur de type B de l'endothéline", "code": { "@type": "MedicalCode", "code": "D065131", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.364.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Activateurs d'enzymes", "alternateName": "Enzyme Activators", "url": "https://questionsmedicales.fr/mesh/D020536", "about": { "@type": "MedicalCondition", "name": "Activateurs d'enzymes", "code": { "@type": "MedicalCode", "code": "D020536", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.374" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Activateurs de la Carbamoyl phosphate synthetase I", "alternateName": "Carbamoyl Phosphate Synthetase I Activators", "url": "https://questionsmedicales.fr/mesh/D065097", "about": { "@type": "MedicalCondition", "name": "Activateurs de la Carbamoyl phosphate synthetase I", "code": { "@type": "MedicalCode", "code": "D065097", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.374.099" } } }, { "@type": "MedicalWebPage", "name": "Activateurs de la GTPase", "alternateName": "GTP Phosphohydrolase Activators", "url": "https://questionsmedicales.fr/mesh/D020549", "about": { "@type": "MedicalCondition", "name": "Activateurs de la GTPase", "code": { "@type": "MedicalCode", "code": "D020549", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.374.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Antienzymes", "alternateName": "Enzyme Inhibitors", "url": "https://questionsmedicales.fr/mesh/D004791", "about": { "@type": "MedicalCondition", "name": "Antienzymes", "code": { "@type": "MedicalCode", "code": "D004791", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des protéines activatrices de la 5-lipoxygénase", "alternateName": "5-Lipoxygenase-Activating Protein Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058946", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des protéines activatrices de la 5-lipoxygénase", "code": { "@type": "MedicalCode", "code": "D058946", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.086" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'acétaldéhyde déshydrogénase", "alternateName": "Acetaldehyde Dehydrogenase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065086", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'acétaldéhyde déshydrogénase", "code": { "@type": "MedicalCode", "code": "D065086", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.089" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'adénosine désaminase", "alternateName": "Adenosine Deaminase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058892", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'adénosine désaminase", "code": { "@type": "MedicalCode", "code": "D058892", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.092" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des adénylate cyclases", "alternateName": "Adenylyl Cyclase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000067956", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des adénylate cyclases", "code": { "@type": "MedicalCode", "code": "D000067956", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.108" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la calcineurine", "alternateName": "Calcineurin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065095", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la calcineurine", "code": { "@type": "MedicalCode", "code": "D065095", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.174" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'anhydrase carbonique", "alternateName": "Carbonic Anhydrase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D002257", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'anhydrase carbonique", "code": { "@type": "MedicalCode", "code": "D002257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.200" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs et modulateurs de la gamma-secrétase", "alternateName": "Gamma Secretase Inhibitors and Modulators", "url": "https://questionsmedicales.fr/mesh/D000091062", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs et modulateurs de la gamma-secrétase", "code": { "@type": "MedicalCode", "code": "D000091062", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.315" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des enzymes du cytochrome P-450", "alternateName": "Cytochrome P-450 Enzyme Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065607", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des enzymes du cytochrome P-450", "code": { "@type": "MedicalCode", "code": "D065607", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP1A2", "alternateName": "Cytochrome P-450 CYP1A2 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065609", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP1A2", "code": { "@type": "MedicalCode", "code": "D065609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.120" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2B6", "alternateName": "Cytochrome P-450 CYP2B6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065686", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2B6", "code": { "@type": "MedicalCode", "code": "D065686", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.260" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C8", "alternateName": "Cytochrome P-450 CYP2C8 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065687", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C8", "code": { "@type": "MedicalCode", "code": "D065687", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.308" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C19", "alternateName": "Cytochrome P-450 CYP2C19 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065689", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C19", "code": { "@type": "MedicalCode", "code": "D065689", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.319" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C9", "alternateName": "Cytochrome P-450 CYP2C9 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065688", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C9", "code": { "@type": "MedicalCode", "code": "D065688", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.329" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2D6", "alternateName": "Cytochrome P-450 CYP2D6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065690", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2D6", "code": { "@type": "MedicalCode", "code": "D065690", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.368" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2E1", "alternateName": "Cytochrome P-450 CYP2E1 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065691", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2E1", "code": { "@type": "MedicalCode", "code": "D065691", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.421" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP3A", "alternateName": "Cytochrome P-450 CYP3A Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065692", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP3A", "code": { "@type": "MedicalCode", "code": "D065692", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.503" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP1A2", "alternateName": "Cytochrome P-450 CYP1A2 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065609", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP1A2", "code": { "@type": "MedicalCode", "code": "D065609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.120" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2B6", "alternateName": "Cytochrome P-450 CYP2B6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065686", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2B6", "code": { "@type": "MedicalCode", "code": "D065686", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.260" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C8", "alternateName": "Cytochrome P-450 CYP2C8 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065687", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C8", "code": { "@type": "MedicalCode", "code": "D065687", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.308" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C19", "alternateName": "Cytochrome P-450 CYP2C19 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065689", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C19", "code": { "@type": "MedicalCode", "code": "D065689", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.319" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2C9", "alternateName": "Cytochrome P-450 CYP2C9 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065688", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2C9", "code": { "@type": "MedicalCode", "code": "D065688", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.329" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2D6", "alternateName": "Cytochrome P-450 CYP2D6 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065690", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2D6", "code": { "@type": "MedicalCode", "code": "D065690", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.368" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP2E1", "alternateName": "Cytochrome P-450 CYP2E1 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065691", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP2E1", "code": { "@type": "MedicalCode", "code": "D065691", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.421" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du cytochrome P-450 CYP3A", "alternateName": "Cytochrome P-450 CYP3A Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065692", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du cytochrome P-450 CYP3A", "code": { "@type": "MedicalCode", "code": "D065692", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.335.503" } } }, { "@type": "MedicalWebPage", "name": "Antifoliques", "alternateName": "Folic Acid Antagonists", "url": "https://questionsmedicales.fr/mesh/D005493", "about": { "@type": "MedicalCondition", "name": "Antifoliques", "code": { "@type": "MedicalCode", "code": "D005493", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.350" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de désacétylase d'histone", "alternateName": "Histone Deacetylase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D056572", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de désacétylase d'histone", "code": { "@type": "MedicalCode", "code": "D056572", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.360" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'intégrase", "alternateName": "Integrase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D019429", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'intégrase", "code": { "@type": "MedicalCode", "code": "D019429", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.375" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la lipoxygénase", "alternateName": "Lipoxygenase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D016859", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la lipoxygénase", "code": { "@type": "MedicalCode", "code": "D016859", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.480" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la monoamine oxydase", "alternateName": "Monoamine Oxidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D008996", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la monoamine oxydase", "code": { "@type": "MedicalCode", "code": "D008996", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.616" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la synthèse d'acide nucléique", "alternateName": "Nucleic Acid Synthesis Inhibitors", "url": "https://questionsmedicales.fr/mesh/D019384", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la synthèse d'acide nucléique", "code": { "@type": "MedicalCode", "code": "D019384", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'ornithine décarboxylase", "alternateName": "Ornithine Decarboxylase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065108", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'ornithine décarboxylase", "code": { "@type": "MedicalCode", "code": "D065108", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.705" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase", "alternateName": "Phosphodiesterase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D010726", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase", "code": { "@type": "MedicalCode", "code": "D010726", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-3", "alternateName": "Phosphodiesterase 3 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058987", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-3", "code": { "@type": "MedicalCode", "code": "D058987", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.249" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-4", "alternateName": "Phosphodiesterase 4 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058988", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-4", "code": { "@type": "MedicalCode", "code": "D058988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.374" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-5", "alternateName": "Phosphodiesterase 5 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058986", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-5", "code": { "@type": "MedicalCode", "code": "D058986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-3", "alternateName": "Phosphodiesterase 3 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058987", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-3", "code": { "@type": "MedicalCode", "code": "D058987", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.249" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-4", "alternateName": "Phosphodiesterase 4 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058988", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-4", "code": { "@type": "MedicalCode", "code": "D058988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.374" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phosphodiestérase-5", "alternateName": "Phosphodiesterase 5 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D058986", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phosphodiestérase-5", "code": { "@type": "MedicalCode", "code": "D058986", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.735.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des phosphoinositide-3 kinases", "alternateName": "Phosphoinositide-3 Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000081082", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des phosphoinositide-3 kinases", "code": { "@type": "MedicalCode", "code": "D000081082", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.736" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la phospholipase A2", "alternateName": "Phospholipase A2 Inhibitors", "url": "https://questionsmedicales.fr/mesh/D064801", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la phospholipase A2", "code": { "@type": "MedicalCode", "code": "D064801", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.737" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de prolyle hydroxylases", "alternateName": "Prolyl-Hydroxylase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D064800", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de prolyle hydroxylases", "code": { "@type": "MedicalCode", "code": "D064800", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.740" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéases", "alternateName": "Protease Inhibitors", "url": "https://questionsmedicales.fr/mesh/D011480", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéases", "code": { "@type": "MedicalCode", "code": "D011480", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'enzyme de conversion de l'angiotensine", "alternateName": "Angiotensin-Converting Enzyme Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000806", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'enzyme de conversion de l'angiotensine", "code": { "@type": "MedicalCode", "code": "D000806", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des vasopeptidases", "alternateName": "Vasopeptidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075563", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des vasopeptidases", "code": { "@type": "MedicalCode", "code": "D000075563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des vasopeptidases", "alternateName": "Vasopeptidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075563", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des vasopeptidases", "code": { "@type": "MedicalCode", "code": "D000075563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la cystéine protéinase", "alternateName": "Cysteine Proteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D015853", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la cystéine protéinase", "code": { "@type": "MedicalCode", "code": "D015853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des caspases", "alternateName": "Caspase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061945", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des caspases", "code": { "@type": "MedicalCode", "code": "D061945", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des caspases", "alternateName": "Caspase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061945", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des caspases", "code": { "@type": "MedicalCode", "code": "D061945", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de métalloprotéinases matricielles", "alternateName": "Matrix Metalloproteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061965", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de métalloprotéinases matricielles", "code": { "@type": "MedicalCode", "code": "D061965", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.610" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du protéasome", "alternateName": "Proteasome Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061988", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du protéasome", "code": { "@type": "MedicalCode", "code": "D061988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.705" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la rénine", "alternateName": "Renin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000092502", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la rénine", "code": { "@type": "MedicalCode", "code": "D000092502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.753" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la sérine protéinase", "alternateName": "Serine Proteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D015842", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la sérine protéinase", "code": { "@type": "MedicalCode", "code": "D015842", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de serine peptidase de type Kazal", "alternateName": "Serine Peptidase Inhibitors, Kazal Type", "url": "https://questionsmedicales.fr/mesh/D000074162", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de serine peptidase de type Kazal", "code": { "@type": "MedicalCode", "code": "D000074162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.562" } } }, { "@type": "MedicalWebPage", "name": "Serpines", "alternateName": "Serpins", "url": "https://questionsmedicales.fr/mesh/D015843", "about": { "@type": "MedicalCondition", "name": "Serpines", "code": { "@type": "MedicalCode", "code": "D015843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs trypsiques", "alternateName": "Trypsin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D014361", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs trypsiques", "code": { "@type": "MedicalCode", "code": "D014361", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de serine peptidase de type Kazal", "alternateName": "Serine Peptidase Inhibitors, Kazal Type", "url": "https://questionsmedicales.fr/mesh/D000074162", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de serine peptidase de type Kazal", "code": { "@type": "MedicalCode", "code": "D000074162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.562" } } }, { "@type": "MedicalWebPage", "name": "Serpines", "alternateName": "Serpins", "url": "https://questionsmedicales.fr/mesh/D015843", "about": { "@type": "MedicalCondition", "name": "Serpines", "code": { "@type": "MedicalCode", "code": "D015843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs trypsiques", "alternateName": "Trypsin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D014361", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs trypsiques", "code": { "@type": "MedicalCode", "code": "D014361", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de l'enzyme de conversion de l'angiotensine", "alternateName": "Angiotensin-Converting Enzyme Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000806", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de l'enzyme de conversion de l'angiotensine", "code": { "@type": "MedicalCode", "code": "D000806", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des vasopeptidases", "alternateName": "Vasopeptidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075563", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des vasopeptidases", "code": { "@type": "MedicalCode", "code": "D000075563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des vasopeptidases", "alternateName": "Vasopeptidase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075563", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des vasopeptidases", "code": { "@type": "MedicalCode", "code": "D000075563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.085.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la cystéine protéinase", "alternateName": "Cysteine Proteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D015853", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la cystéine protéinase", "code": { "@type": "MedicalCode", "code": "D015853", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des caspases", "alternateName": "Caspase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061945", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des caspases", "code": { "@type": "MedicalCode", "code": "D061945", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des caspases", "alternateName": "Caspase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061945", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des caspases", "code": { "@type": "MedicalCode", "code": "D061945", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.325.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de métalloprotéinases matricielles", "alternateName": "Matrix Metalloproteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061965", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de métalloprotéinases matricielles", "code": { "@type": "MedicalCode", "code": "D061965", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.610" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs du protéasome", "alternateName": "Proteasome Inhibitors", "url": "https://questionsmedicales.fr/mesh/D061988", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du protéasome", "code": { "@type": "MedicalCode", "code": "D061988", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.705" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la rénine", "alternateName": "Renin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000092502", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la rénine", "code": { "@type": "MedicalCode", "code": "D000092502", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.753" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la sérine protéinase", "alternateName": "Serine Proteinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D015842", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la sérine protéinase", "code": { "@type": "MedicalCode", "code": "D015842", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs de serine peptidase de type Kazal", "alternateName": "Serine Peptidase Inhibitors, Kazal Type", "url": "https://questionsmedicales.fr/mesh/D000074162", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de serine peptidase de type Kazal", "code": { "@type": "MedicalCode", "code": "D000074162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.562" } } }, { "@type": "MedicalWebPage", "name": "Serpines", "alternateName": "Serpins", "url": "https://questionsmedicales.fr/mesh/D015843", "about": { "@type": "MedicalCondition", "name": "Serpines", "code": { "@type": "MedicalCode", "code": "D015843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs trypsiques", "alternateName": "Trypsin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D014361", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs trypsiques", "code": { "@type": "MedicalCode", "code": "D014361", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.900" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de serine peptidase de type Kazal", "alternateName": "Serine Peptidase Inhibitors, Kazal Type", "url": "https://questionsmedicales.fr/mesh/D000074162", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de serine peptidase de type Kazal", "code": { "@type": "MedicalCode", "code": "D000074162", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.562" } } }, { "@type": "MedicalWebPage", "name": "Serpines", "alternateName": "Serpins", "url": "https://questionsmedicales.fr/mesh/D015843", "about": { "@type": "MedicalCondition", "name": "Serpines", "code": { "@type": "MedicalCode", "code": "D015843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.675" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs trypsiques", "alternateName": "Trypsin Inhibitors", "url": "https://questionsmedicales.fr/mesh/D014361", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs trypsiques", "code": { "@type": "MedicalCode", "code": "D014361", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.745.800.900" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéines kinases", "alternateName": "Protein Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D047428", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéines kinases", "code": { "@type": "MedicalCode", "code": "D047428", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs des Janus kinases", "alternateName": "Janus Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075242", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des Janus kinases", "code": { "@type": "MedicalCode", "code": "D000075242", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéine-tyrosine kinase", "alternateName": "Tyrosine Protein Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000092004", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéine-tyrosine kinase", "code": { "@type": "MedicalCode", "code": "D000092004", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Inhibiteurs des Janus kinases", "alternateName": "Janus Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000075242", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs des Janus kinases", "code": { "@type": "MedicalCode", "code": "D000075242", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de protéine-tyrosine kinase", "alternateName": "Tyrosine Protein Kinase Inhibitors", "url": "https://questionsmedicales.fr/mesh/D000092004", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de protéine-tyrosine kinase", "code": { "@type": "MedicalCode", "code": "D000092004", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.755.875" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la synthèse protéique", "alternateName": "Protein Synthesis Inhibitors", "url": "https://questionsmedicales.fr/mesh/D011500", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la synthèse protéique", "code": { "@type": "MedicalCode", "code": "D011500", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.760" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de la pompe à protons", "alternateName": "Proton Pump Inhibitors", "url": "https://questionsmedicales.fr/mesh/D054328", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de la pompe à protons", "code": { "@type": "MedicalCode", "code": "D054328", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.848" } } }, { "@type": "MedicalWebPage", "name": "Agents découplants", "alternateName": "Uncoupling Agents", "url": "https://questionsmedicales.fr/mesh/D014475", "about": { "@type": "MedicalCondition", "name": "Agents découplants", "code": { "@type": "MedicalCode", "code": "D014475", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.389.936" } } } ] }, { "@type": "MedicalWebPage", "name": "Réactivateurs d'enzymes", "alternateName": "Enzyme Reactivators", "url": "https://questionsmedicales.fr/mesh/D004793", "about": { "@type": "MedicalCondition", "name": "Réactivateurs d'enzymes", "code": { "@type": "MedicalCode", "code": "D004793", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.405" } } }, { "@type": "MedicalWebPage", "name": "Modulateurs de la fibrinolyse", "alternateName": "Fibrin Modulating Agents", "url": "https://questionsmedicales.fr/mesh/D050299", "about": { "@type": "MedicalCondition", "name": "Modulateurs de la fibrinolyse", "code": { "@type": "MedicalCode", "code": "D050299", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.421" } } }, { "@type": "MedicalWebPage", "name": "Modulateurs du transport transmembranaire", "alternateName": "Membrane Transport Modulators", "url": "https://questionsmedicales.fr/mesh/D049990", "about": { "@type": "MedicalCondition", "name": "Modulateurs du transport transmembranaire", "code": { "@type": "MedicalCode", "code": "D049990", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Agonistes de canaux chlorure", "alternateName": "Chloride Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D065101", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux chlorure", "code": { "@type": "MedicalCode", "code": "D065101", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.311" } } }, { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques", "alternateName": "Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D062687", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques", "code": { "@type": "MedicalCode", "code": "D062687", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques épithéliaux", "alternateName": "Epithelial Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D062708", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques épithéliaux", "code": { "@type": "MedicalCode", "code": "D062708", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625.249" } } }, { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques voltage-dépendants", "alternateName": "Voltage-Gated Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D061585", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques voltage-dépendants", "code": { "@type": "MedicalCode", "code": "D061585", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques épithéliaux", "alternateName": "Epithelial Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D062708", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques épithéliaux", "code": { "@type": "MedicalCode", "code": "D062708", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625.249" } } }, { "@type": "MedicalWebPage", "name": "Agonistes de canaux sodiques voltage-dépendants", "alternateName": "Voltage-Gated Sodium Channel Agonists", "url": "https://questionsmedicales.fr/mesh/D061585", "about": { "@type": "MedicalCondition", "name": "Agonistes de canaux sodiques voltage-dépendants", "code": { "@type": "MedicalCode", "code": "D061585", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.625.500" } } }, { "@type": "MedicalWebPage", "name": "Inhibiteurs de canaux ioniques sensibles à l'acidité", "alternateName": "Acid Sensing Ion Channel Blockers", "url": "https://questionsmedicales.fr/mesh/D062646", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs de canaux ioniques sensibles à l'acidité", "code": { "@type": "MedicalCode", "code": "D062646", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.562.750.100" } } } ] }, { "@type": "MedicalWebPage", "name": "Modulateurs de la mitose", "alternateName": "Mitosis Modulators", "url": "https://questionsmedicales.fr/mesh/D050258", "about": { "@type": "MedicalCondition", "name": "Modulateurs de la mitose", "code": { "@type": "MedicalCode", "code": "D050258", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.593" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Modulateurs de la polymérisation de la tubuline", "alternateName": "Tubulin Modulators", "url": "https://questionsmedicales.fr/mesh/D050257", "about": { "@type": "MedicalCondition", "name": "Modulateurs de la polymérisation de la tubuline", "code": { "@type": "MedicalCode", "code": "D050257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.593.249.500" } } }, { "@type": "MedicalWebPage", "name": "Mitogènes", "alternateName": "Mitogens", "url": "https://questionsmedicales.fr/mesh/D008934", "about": { "@type": "MedicalCondition", "name": "Mitogènes", "code": { "@type": "MedicalCode", "code": "D008934", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.593.624" } } } ] }, { "@type": "MedicalWebPage", "name": "Gazotransmetteurs", "alternateName": "Gasotransmitters", "url": "https://questionsmedicales.fr/mesh/D064426", "about": { "@type": "MedicalCondition", "name": "Gazotransmetteurs", "code": { "@type": "MedicalCode", "code": "D064426", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.625.270" } } }, { "@type": "MedicalWebPage", "name": "Peptidomimétiques", "alternateName": "Peptidomimetics", "url": "https://questionsmedicales.fr/mesh/D057786", "about": { "@type": "MedicalCondition", "name": "Peptidomimétiques", "code": { "@type": "MedicalCode", "code": "D057786", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.519.828" } } } ], "about": { "@type": "MedicalCondition", "name": "Mécanismes moléculaires de l'action pharmacologique", "alternateName": "Molecular Mechanisms of Pharmacological Action", "code": { "@type": "MedicalCode", "code": "D045504", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Javad Sharifi-Rad", "url": "https://questionsmedicales.fr/author/Javad%20Sharifi-Rad", "affiliation": { "@type": "Organization", "name": "Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran." } }, { "@type": "Person", "name": "Daniela Calina", "url": "https://questionsmedicales.fr/author/Daniela%20Calina", "affiliation": { "@type": "Organization", "name": "Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania." } }, { "@type": "Person", "name": "Yi Li", "url": "https://questionsmedicales.fr/author/Yi%20Li", "affiliation": { "@type": "Organization", "name": "The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China." } }, { "@type": "Person", "name": "Yan Wang", "url": "https://questionsmedicales.fr/author/Yan%20Wang", "affiliation": { "@type": "Organization", "name": "The Second Medical College, Binzhou Medical University, Yantai, Shandong, China." } }, { "@type": "Person", "name": "Ibrahim Jantan", "url": "https://questionsmedicales.fr/author/Ibrahim%20Jantan", "affiliation": { "@type": "Organization", "name": "Institute of Systems Biology, Universiti Kebangsaan Malaysia, Selangor, Malaysia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "The Molecular Pharmacology of Phloretin: Anti-Inflammatory Mechanisms of Action.", "datePublished": "2023-01-06", "url": "https://questionsmedicales.fr/article/36672652", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/biomedicines11010143" } }, { "@type": "ScholarlyArticle", "name": "Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action.", "datePublished": "2023-05-03", "url": "https://questionsmedicales.fr/article/37133685", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s40268-023-00419-5" } }, { "@type": "ScholarlyArticle", "name": "Identifying the Multitarget Pharmacological Mechanism of Action of Genistein on Lung Cancer by Integrating Network Pharmacology and Molecular Dynamic Simulation.", "datePublished": "2024-04-23", "url": "https://questionsmedicales.fr/article/38731403", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/molecules29091913" } }, { "@type": "ScholarlyArticle", "name": "Network Pharmacology Revealed the Mechanisms of Action of", "datePublished": "2023-03-13", "url": "https://questionsmedicales.fr/article/36936755", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/CCID.S403736" } }, { "@type": "ScholarlyArticle", "name": "Erratum: Exploring the pharmacological action mechanism of", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36467070", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fphar.2022.1089017" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Mécanismes moléculaires de l'action pharmacologique", "item": "https://questionsmedicales.fr/mesh/D045504" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mécanismes moléculaires de l'action pharmacologique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mécanismes moléculaires de l'action pharmacologique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-29", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mécanismes moléculaires de l'action pharmacologique", "description": "Comment identifier un mécanisme d'action d'un médicament ?\nQuels tests sont utilisés pour étudier les mécanismes moléculaires ?\nQuelles techniques d'imagerie aident au diagnostic ?\nComment les biomarqueurs sont-ils utilisés dans le diagnostic ?\nQuel rôle joue la pharmacogénomique dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D045504#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mécanismes moléculaires de l'action pharmacologique", "description": "Quels symptômes indiquent un effet pharmacologique ?\nComment les effets indésirables sont-ils liés aux mécanismes d'action ?\nQuels symptômes sont associés aux médicaments ciblant les récepteurs ?\nComment les symptômes varient-ils selon les mécanismes d'action ?\nQuels symptômes peuvent indiquer une surdose ?", "url": "https://questionsmedicales.fr/mesh/D045504#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mécanismes moléculaires de l'action pharmacologique", "description": "Comment prévenir les effets indésirables des médicaments ?\nQuel rôle joue l'éducation des patients dans la prévention ?\nComment les études cliniques aident-elles à prévenir les complications ?\nQuels facteurs influencent la prévention des effets indésirables ?\nComment les recommandations de traitement aident-elles à prévenir les risques ?", "url": "https://questionsmedicales.fr/mesh/D045504#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mécanismes moléculaires de l'action pharmacologique", "description": "Comment les médicaments ciblent-ils des mécanismes spécifiques ?\nQuels traitements utilisent des mécanismes d'action innovants ?\nComment les traitements sont-ils personnalisés ?\nQuel est l'impact des mécanismes d'action sur l'efficacité des traitements ?\nComment les combinaisons de médicaments exploitent les mécanismes d'action ?", "url": "https://questionsmedicales.fr/mesh/D045504#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mécanismes moléculaires de l'action pharmacologique", "description": "Quelles complications peuvent survenir avec des médicaments ?\nComment les mécanismes d'action influencent-ils les complications ?\nQuels sont les signes de complications graves ?\nComment gérer les complications liées aux médicaments ?\nQuel rôle joue la pharmacovigilance dans la détection des complications ?", "url": "https://questionsmedicales.fr/mesh/D045504#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mécanismes moléculaires de l'action pharmacologique", "description": "Quels facteurs de risque influencent l'efficacité des médicaments ?\nComment les interactions médicamenteuses sont-elles un facteur de risque ?\nQuel impact a l'alimentation sur les mécanismes d'action ?\nComment le mode de vie affecte-t-il les traitements ?\nQuels facteurs environnementaux influencent les effets des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D045504#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un mécanisme d'action d'un médicament ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse des interactions moléculaires et des voies de signalisation aide à identifier les mécanismes." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour étudier les mécanismes moléculaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests in vitro, des études de liaison et des analyses génétiques sont couramment utilisés." } }, { "@type": "Question", "name": "Quelles techniques d'imagerie aident au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie par résonance magnétique et la tomographie permettent d'observer les effets des médicaments." } }, { "@type": "Question", "name": "Comment les biomarqueurs sont-ils utilisés dans le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les biomarqueurs aident à évaluer l'efficacité et la sécurité des médicaments en fonction de leur mécanisme." } }, { "@type": "Question", "name": "Quel rôle joue la pharmacogénomique dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'adapter les traitements en fonction des variations génétiques influençant les mécanismes d'action." } }, { "@type": "Question", "name": "Quels symptômes indiquent un effet pharmacologique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des changements physiologiques, des effets secondaires ou des améliorations cliniques." } }, { "@type": "Question", "name": "Comment les effets indésirables sont-ils liés aux mécanismes d'action ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les effets indésirables résultent souvent d'interactions non spécifiques avec des cibles moléculaires." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux médicaments ciblant les récepteurs ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure des modifications de la perception, de l'humeur ou de la douleur." } }, { "@type": "Question", "name": "Comment les symptômes varient-ils selon les mécanismes d'action ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient en fonction des cibles moléculaires et des voies de signalisation affectées." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une surdose ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes tels que des nausées, des vertiges ou des troubles de la conscience peuvent indiquer une surdose." } }, { "@type": "Question", "name": "Comment prévenir les effets indésirables des médicaments ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation des mécanismes d'action et des interactions médicamenteuses peut aider à prévenir les effets indésirables." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation des patients dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation des patients sur les mécanismes d'action des médicaments peut améliorer l'adhésion et réduire les risques." } }, { "@type": "Question", "name": "Comment les études cliniques aident-elles à prévenir les complications ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les études cliniques identifient les mécanismes d'action et les effets indésirables potentiels, permettant une meilleure prévention." } }, { "@type": "Question", "name": "Quels facteurs influencent la prévention des effets indésirables ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la génétique, l'âge, les comorbidités et les interactions médicamenteuses." } }, { "@type": "Question", "name": "Comment les recommandations de traitement aident-elles à prévenir les risques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les recommandations basées sur les mécanismes d'action aident à choisir des traitements plus sûrs et efficaces." } }, { "@type": "Question", "name": "Comment les médicaments ciblent-ils des mécanismes spécifiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments sont conçus pour interagir avec des cibles moléculaires spécifiques, comme des enzymes ou des récepteurs." } }, { "@type": "Question", "name": "Quels traitements utilisent des mécanismes d'action innovants ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies géniques et les médicaments biologiques exploitent des mécanismes d'action novateurs." } }, { "@type": "Question", "name": "Comment les traitements sont-ils personnalisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements sont adaptés en fonction des caractéristiques moléculaires des patients et des médicaments." } }, { "@type": "Question", "name": "Quel est l'impact des mécanismes d'action sur l'efficacité des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une compréhension approfondie des mécanismes d'action permet d'optimiser l'efficacité et de réduire les effets secondaires." } }, { "@type": "Question", "name": "Comment les combinaisons de médicaments exploitent les mécanismes d'action ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les combinaisons de médicaments peuvent cibler plusieurs mécanismes pour améliorer l'efficacité thérapeutique." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des médicaments ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des réactions allergiques, des effets toxiques ou des interactions médicamenteuses." } }, { "@type": "Question", "name": "Comment les mécanismes d'action influencent-ils les complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les mécanismes d'action peuvent déterminer la sévérité et la nature des complications observées." } }, { "@type": "Question", "name": "Quels sont les signes de complications graves ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des signes tels que des difficultés respiratoires, des éruptions cutanées ou des douleurs thoraciques peuvent indiquer des complications graves." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux médicaments ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications implique l'arrêt du médicament, le traitement des symptômes et la surveillance étroite." } }, { "@type": "Question", "name": "Quel rôle joue la pharmacovigilance dans la détection des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La pharmacovigilance surveille les effets indésirables et les complications pour améliorer la sécurité des médicaments." } }, { "@type": "Question", "name": "Quels facteurs de risque influencent l'efficacité des médicaments ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, le sexe, la génétique et les comorbidités qui peuvent affecter l'efficacité." } }, { "@type": "Question", "name": "Comment les interactions médicamenteuses sont-elles un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les interactions médicamenteuses peuvent altérer les mécanismes d'action et augmenter le risque d'effets indésirables." } }, { "@type": "Question", "name": "Quel impact a l'alimentation sur les mécanismes d'action ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'alimentation peut influencer l'absorption et le métabolisme des médicaments, affectant leur efficacité." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il les traitements ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le mode de vie, y compris l'exercice et le tabagisme, peut modifier la réponse aux médicaments et leurs mécanismes d'action." } }, { "@type": "Question", "name": "Quels facteurs environnementaux influencent les effets des médicaments ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs environnementaux, comme la pollution, peuvent interagir avec les mécanismes d'action des médicaments." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 10/02/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

86 au total
└─

Antagonistes des récepteurs aux angiotensines

Angiotensin Receptor Antagonists D057911 - D27.505.519.162
└─

Agents antiglycation

Antiglycation Agents D000093744 - D27.505.519.182
└─

Antagonistes des récepteurs de la bradykinine

Bradykinin Receptor Antagonists D065168 - D27.505.519.265
└─

Agents de déplétion en cystine

Cystine Depleting Agents D065104 - D27.505.519.334
└─

Inducteurs des enzymes du cytochrome P-450

Cytochrome P-450 Enzyme Inducers D065693 - D27.505.519.349
└─

Antagonistes des récepteurs de l'endothéline

Endothelin Receptor Antagonists D065128 - D27.505.519.364
└─

Activateurs d'enzymes

Enzyme Activators D020536 - D27.505.519.374
└─

Antienzymes

Enzyme Inhibitors D004791 - D27.505.519.389
└─

Réactivateurs d'enzymes

Enzyme Reactivators D004793 - D27.505.519.405
└─

Modulateurs de la fibrinolyse

Fibrin Modulating Agents D050299 - D27.505.519.421
└─

Modulateurs du transport transmembranaire

Membrane Transport Modulators D049990 - D27.505.519.562
└─

Modulateurs de la mitose

Mitosis Modulators D050258 - D27.505.519.593
└─

Peptidomimétiques

Peptidomimetics D057786 - D27.505.519.828
└─└─

Antagonistes du récepteur de type 1 de l'angiotensine-II

Angiotensin II Type 1 Receptor Blockers D047228 - D27.505.519.162.500
└─└─

Antagonistes du récepteur de type 2 de l'angiotensine-II

Angiotensin II Type 2 Receptor Blockers D057912 - D27.505.519.162.750
└─└─

Piégeurs de radicaux libres

Free Radical Scavengers D016166 - D27.505.519.217.500
└─└─

Antagonistes du récepteur B1 de la bradykinine

Bradykinin B1 Receptor Antagonists D065169 - D27.505.519.265.249
└─└─

Inducteurs du cytochrome P-450 CYP1A2

Cytochrome P-450 CYP1A2 Inducers D065694 - D27.505.519.349.120
└─└─

Inducteurs du cytochrome P-450 CYP2B6

Cytochrome P-450 CYP2B6 Inducers D065695 - D27.505.519.349.260
└─└─

Inducteurs du cytochrome P-450 CYP2C8

Cytochrome P-450 CYP2C8 Inducers D065696 - D27.505.519.349.308
└─└─

Inducteurs du cytochrome P-450 CYP2C9

Cytochrome P-450 CYP2C9 Inducers D065698 - D27.505.519.349.320
└─└─

Inducteurs du cytochrome P-450 CYP2C19

Cytochrome P-450 CYP2C19 Inducers D065697 - D27.505.519.349.350
└─└─

Inducteurs du cytochrome P-450 CYP2D6

Cytochrome P-450 CYP2D6 Inducers D065699 - D27.505.519.349.500
└─└─

Inducteurs du cytochrome P-450 CYP2E1

Cytochrome P-450 CYP2E1 Inducers D065700 - D27.505.519.349.600
└─└─

Inducteurs du cytochrome P-450 CYP3A

Cytochrome P-450 CYP3A Inducers D065701 - D27.505.519.349.700
└─└─

Antagonistes du récepteur de type A de l'endothéline

Endothelin A Receptor Antagonists D065130 - D27.505.519.364.500
└─└─

Antagonistes du récepteur de type B de l'endothéline

Endothelin B Receptor Antagonists D065131 - D27.505.519.364.750
└─└─

Activateurs de la Carbamoyl phosphate synthetase I

Carbamoyl Phosphate Synthetase I Activators D065097 - D27.505.519.374.099
└─└─

Activateurs de la GTPase

GTP Phosphohydrolase Activators D020549 - D27.505.519.374.200
└─└─

Inhibiteurs des protéines activatrices de la 5-lipoxygénase

5-Lipoxygenase-Activating Protein Inhibitors D058946 - D27.505.519.389.086
└─└─

Inhibiteurs de l'acétaldéhyde déshydrogénase

Acetaldehyde Dehydrogenase Inhibitors D065086 - D27.505.519.389.089
└─└─

Inhibiteurs de l'adénosine désaminase

Adenosine Deaminase Inhibitors D058892 - D27.505.519.389.092
└─└─

Inhibiteurs des adénylate cyclases

Adenylyl Cyclase Inhibitors D000067956 - D27.505.519.389.108
└─└─

Inhibiteurs de la calcineurine

Calcineurin Inhibitors D065095 - D27.505.519.389.174
└─└─

Inhibiteurs de l'anhydrase carbonique

Carbonic Anhydrase Inhibitors D002257 - D27.505.519.389.200
└─└─

Inhibiteurs et modulateurs de la gamma-secrétase

Gamma Secretase Inhibitors and Modulators D000091062 - D27.505.519.389.315
└─└─

Inhibiteurs des enzymes du cytochrome P-450

Cytochrome P-450 Enzyme Inhibitors D065607 - D27.505.519.389.335
└─└─

Antifoliques

Folic Acid Antagonists D005493 - D27.505.519.389.350
└─└─

Inhibiteurs de désacétylase d'histone

Histone Deacetylase Inhibitors D056572 - D27.505.519.389.360
└─└─

Inhibiteurs de l'intégrase

Integrase Inhibitors D019429 - D27.505.519.389.375
└─└─

Inhibiteurs de la lipoxygénase

Lipoxygenase Inhibitors D016859 - D27.505.519.389.480
└─└─

Inhibiteurs de la monoamine oxydase

Monoamine Oxidase Inhibitors D008996 - D27.505.519.389.616
└─└─

Inhibiteurs de la synthèse d'acide nucléique

Nucleic Acid Synthesis Inhibitors D019384 - D27.505.519.389.675
└─└─

Inhibiteurs de l'ornithine décarboxylase

Ornithine Decarboxylase Inhibitors D065108 - D27.505.519.389.705
└─└─

Inhibiteurs de la phosphodiestérase

Phosphodiesterase Inhibitors D010726 - D27.505.519.389.735
└─└─

Inhibiteurs des phosphoinositide-3 kinases

Phosphoinositide-3 Kinase Inhibitors D000081082 - D27.505.519.389.736
└─└─

Inhibiteurs de la phospholipase A2

Phospholipase A2 Inhibitors D064801 - D27.505.519.389.737
└─└─

Inhibiteurs de prolyle hydroxylases

Prolyl-Hydroxylase Inhibitors D064800 - D27.505.519.389.740
└─└─

Inhibiteurs de protéases

Protease Inhibitors D011480 - D27.505.519.389.745
└─└─

Inhibiteurs de protéines kinases

Protein Kinase Inhibitors D047428 - D27.505.519.389.755
└─└─

Inhibiteurs de la synthèse protéique

Protein Synthesis Inhibitors D011500 - D27.505.519.389.760
└─└─

Inhibiteurs de la pompe à protons

Proton Pump Inhibitors D054328 - D27.505.519.389.848
└─└─

Agents découplants

Uncoupling Agents D014475 - D27.505.519.389.936
└─└─

Agonistes de canaux chlorure

Chloride Channel Agonists D065101 - D27.505.519.562.311
└─└─

Agonistes de canaux sodiques

Sodium Channel Agonists D062687 - D27.505.519.562.625
└─└─

Mitogènes

Mitogens D008934 - D27.505.519.593.624
└─└─

Gazotransmetteurs

Gasotransmitters D064426 - D27.505.519.625.270
└─└─└─

Inhibiteurs de la synthèse d'acides gras

Fatty Acid Synthesis Inhibitors D054872 - D27.505.519.186.071.401
└─└─└─

Inhibiteurs du cytochrome P-450 CYP1A2

Cytochrome P-450 CYP1A2 Inhibitors D065609 - D27.505.519.389.335.120
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2B6

Cytochrome P-450 CYP2B6 Inhibitors D065686 - D27.505.519.389.335.260
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2C8

Cytochrome P-450 CYP2C8 Inhibitors D065687 - D27.505.519.389.335.308
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2C19

Cytochrome P-450 CYP2C19 Inhibitors D065689 - D27.505.519.389.335.319
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2C9

Cytochrome P-450 CYP2C9 Inhibitors D065688 - D27.505.519.389.335.329
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2D6

Cytochrome P-450 CYP2D6 Inhibitors D065690 - D27.505.519.389.335.368
└─└─└─

Inhibiteurs du cytochrome P-450 CYP2E1

Cytochrome P-450 CYP2E1 Inhibitors D065691 - D27.505.519.389.335.421
└─└─└─

Inhibiteurs du cytochrome P-450 CYP3A

Cytochrome P-450 CYP3A Inhibitors D065692 - D27.505.519.389.335.503
└─└─└─

Inhibiteurs de la phosphodiestérase-3

Phosphodiesterase 3 Inhibitors D058987 - D27.505.519.389.735.249
└─└─└─

Inhibiteurs de la phosphodiestérase-4

Phosphodiesterase 4 Inhibitors D058988 - D27.505.519.389.735.374
└─└─└─

Inhibiteurs de la phosphodiestérase-5

Phosphodiesterase 5 Inhibitors D058986 - D27.505.519.389.735.500
└─└─└─

Inhibiteurs de l'enzyme de conversion de l'angiotensine

Angiotensin-Converting Enzyme Inhibitors D000806 - D27.505.519.389.745.085
└─└─└─

Inhibiteurs de la cystéine protéinase

Cysteine Proteinase Inhibitors D015853 - D27.505.519.389.745.325
└─└─└─

Inhibiteurs de métalloprotéinases matricielles

Matrix Metalloproteinase Inhibitors D061965 - D27.505.519.389.745.610
└─└─└─

Inhibiteurs du protéasome

Proteasome Inhibitors D061988 - D27.505.519.389.745.705
└─└─└─

Inhibiteurs de la rénine

Renin Inhibitors D000092502 - D27.505.519.389.745.753
└─└─└─

Inhibiteurs de la sérine protéinase

Serine Proteinase Inhibitors D015842 - D27.505.519.389.745.800
└─└─└─

Inhibiteurs des Janus kinases

Janus Kinase Inhibitors D000075242 - D27.505.519.389.755.500
└─└─└─

Inhibiteurs de protéine-tyrosine kinase

Tyrosine Protein Kinase Inhibitors D000092004 - D27.505.519.389.755.875
└─└─└─

Agonistes de canaux sodiques épithéliaux

Epithelial Sodium Channel Agonists D062708 - D27.505.519.562.625.249
└─└─└─

Agonistes de canaux sodiques voltage-dépendants

Voltage-Gated Sodium Channel Agonists D061585 - D27.505.519.562.625.500
└─└─└─

Inhibiteurs de canaux ioniques sensibles à l'acidité

Acid Sensing Ion Channel Blockers D062646 - D27.505.519.562.750.100
└─└─└─

Modulateurs de la polymérisation de la tubuline

Tubulin Modulators D050257 - D27.505.519.593.249.500
└─└─└─└─

Inhibiteurs des vasopeptidases

Vasopeptidase Inhibitors D000075563 - D27.505.519.389.745.085.500
└─└─└─└─

Inhibiteurs des caspases

Caspase Inhibitors D061945 - D27.505.519.389.745.325.500
└─└─└─└─

Inhibiteurs de serine peptidase de type Kazal

Serine Peptidase Inhibitors, Kazal Type D000074162 - D27.505.519.389.745.800.562
└─└─└─└─

Serpines

Serpins D015843 - D27.505.519.389.745.800.675
└─└─└─└─

Inhibiteurs trypsiques

Trypsin Inhibitors D014361 - D27.505.519.389.745.800.900

Auteurs principaux

Javad Sharifi-Rad

2 publications dans cette catégorie

Affiliations :
  • Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Daniela Calina

2 publications dans cette catégorie

Affiliations :
  • Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Yi Li

2 publications dans cette catégorie

Affiliations :
  • The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.

Yan Wang

2 publications dans cette catégorie

Affiliations :
  • The Second Medical College, Binzhou Medical University, Yantai, Shandong, China.
  • Department of Otolaryngology and Head and Neck Surgery, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China.
  • Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai, Shandong, China.

Ibrahim Jantan

2 publications dans cette catégorie

Affiliations :
  • Institute of Systems Biology, Universiti Kebangsaan Malaysia, Selangor, Malaysia.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Juriyati Jalil

2 publications dans cette catégorie

Affiliations :
  • Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Syaratul Dalina Yusoff

2 publications dans cette catégorie

Affiliations :
  • Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Khairana Husain

2 publications dans cette catégorie

Affiliations :
  • Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Wei Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Traditional Medicine, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Lin Li

2 publications dans cette catégorie

Affiliations :
  • Institute of Traditional Chinese Medicine Diagnostics, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China.

Ying Huai

2 publications dans cette catégorie

Affiliations :
  • Lab for Bone Metabolism, Key Lab for Space Biosciences and Biotechnology, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Wei Wang

2 publications dans cette catégorie

Affiliations :
  • Lab for Bone Metabolism, Key Lab for Space Biosciences and Biotechnology, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Kai Dang

2 publications dans cette catégorie

Affiliations :
  • Lab for Bone Metabolism, Key Lab for Space Biosciences and Biotechnology, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; Research Center for Special Medicine and Health Systems Engineering, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China; NPU-UAB Joint Laboratory for Bone Metabolism, School of Life Science, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Solomon Habtemariam

1 publication dans cette catégorie

Affiliations :
  • Pharmacognosy Research & Herbal Analysis Services UK, University of Greenwich, Central Avenue, Chatham-Maritime, Kent ME4 4TB, UK.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Senem Kamiloglu

1 publication dans cette catégorie

Affiliations :
  • Science and Technology Application and Research Center (BITAUM), Bursa Uludag University, Bursa, Turkey.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Balakyz Yeskaliyeva

1 publication dans cette catégorie

Affiliations :
  • Faculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Ahmet Beyatli

1 publication dans cette catégorie

Affiliations :
  • Department of Medicinal and Aromatic Plants, University of Health Sciences, Istanbul, Turkey.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Mary Angelia Alfred

1 publication dans cette catégorie

Affiliations :
  • Department of Chemistry, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, India.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Bahare Salehi

1 publication dans cette catégorie

Affiliations :
  • Medical Ethics and Law Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Anca Oana Docea

1 publication dans cette catégorie

Affiliations :
  • Department of Toxicology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Publications dans "Mécanismes moléculaires de l'action pharmacologique" :

Sources (10000 au total)

Identifying the Multitarget Pharmacological Mechanism of Action of Genistein on Lung Cancer by Integrating Network Pharmacology and Molecular Dynamic Simulation.

Food supplements have become beneficial as adjuvant therapies for many chronic disorders, including cancer. Genistein, a natural isoflavone enriched in soybeans, has gained potential interest as an an...

Network Pharmacology Revealed the Mechanisms of Action of

The application of network analysis algorithms promoted the development of network pharmacology. This study aimed to combine network pharmacology and signed random walk with restart (SRWR) to reveal t... The compounds and targets of LES were retrieved from Traditional Chinese Medicine Integrated Database (TCMID) and Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMS... We found that active LES-derived compounds such as caffeic acid, Isovaleric acid, Arnebinol, and Alannan may inhibit PTGS2, HSP90AA1 and MAPK14, which are key mediators involved in PI3K-Akt pathway, v... The application of SRWR could identify potential targets of LES with a low false-positive rate and help elucidate the mechanism of action of traditional Chinese medicine....

Use of network pharmacology and molecular docking to explore the mechanism of action of curcuma in the treatment of osteosarcoma.

Curcuma has been used as an adjuvant treatment for osteosarcoma (OS) due to its anticancer compounds. However, the underlying mechanism remains unclear. Therefore, this study aimed to explore the mech...

Potential molecular mechanisms of Erlongjiaonang action in idiopathic sudden hearing loss: A network pharmacology and molecular docking analyses.

Idiopathic sudden hearing loss (ISHL) is characterized by sudden unexplainable and unilateral hearing loss as a clinically emergent symptom. The use of the herb Erlongjiaonang (ELJN) in traditional Ch... The Traditional Chinese Medicine System Pharmacological database and the Swiss Target Prediction database were searched for the identification of ELJN constituents and potential gene targets, respecti... Erlongjiaonang contains 85 components and 250 corresponding gene targets, while ISHL has 714 disease-related targets, resulting in 66 cross-targets. The bioinformatical analyses revealed these 66 cros... This study uncovered potential ELJN gene targets and molecular signaling pathways in the control of ISHL, providing a molecular basis for further investigation of the anti-ISHL activity of ELJN....